BR112015027026A2 - composição para uso na redução da formação de crosta e na promoção da cicatrização - Google Patents

composição para uso na redução da formação de crosta e na promoção da cicatrização

Info

Publication number
BR112015027026A2
BR112015027026A2 BR112015027026A BR112015027026A BR112015027026A2 BR 112015027026 A2 BR112015027026 A2 BR 112015027026A2 BR 112015027026 A BR112015027026 A BR 112015027026A BR 112015027026 A BR112015027026 A BR 112015027026A BR 112015027026 A2 BR112015027026 A2 BR 112015027026A2
Authority
BR
Brazil
Prior art keywords
composition
promoting healing
crust formation
reducing
reducing crust
Prior art date
Application number
BR112015027026A
Other languages
English (en)
Other versions
BR112015027026A8 (pt
Inventor
Svensson Birgitta
Linsefors Lotta
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of BR112015027026A2 publication Critical patent/BR112015027026A2/pt
Publication of BR112015027026A8 publication Critical patent/BR112015027026A8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112015027026A 2013-04-26 2014-04-23 composição para uso na redução da formação de casca e na promoção da cicatrização BR112015027026A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1350518 2013-04-26
PCT/SE2014/050487 WO2014175814A1 (en) 2013-04-26 2014-04-23 Composition for use in reducing scab formation and promoting healing

Publications (2)

Publication Number Publication Date
BR112015027026A2 true BR112015027026A2 (pt) 2017-07-25
BR112015027026A8 BR112015027026A8 (pt) 2018-01-30

Family

ID=51792217

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015027026A BR112015027026A8 (pt) 2013-04-26 2014-04-23 composição para uso na redução da formação de casca e na promoção da cicatrização

Country Status (10)

Country Link
US (1) US20160081968A1 (pt)
EP (1) EP2988731B1 (pt)
CN (1) CN105338963A (pt)
AU (1) AU2014257984B2 (pt)
BR (1) BR112015027026A8 (pt)
CA (1) CA2910114A1 (pt)
ES (1) ES2860578T3 (pt)
HK (1) HK1224175A1 (pt)
PL (1) PL2988731T3 (pt)
WO (1) WO2014175814A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
CN110087631A (zh) * 2016-12-16 2019-08-02 北欧油脂集团(上市公司) 矿脂替代品制剂
JP7364556B2 (ja) * 2017-05-23 2023-10-18 ファーミバ アーベー 体腔に活性物質を送達するための泡形成性組成物
CN108697629B (zh) * 2017-09-05 2021-10-15 拉芳家化股份有限公司 一种天然替代的植物精油防腐剂及在化妆品中的应用
US11166925B2 (en) 2018-08-23 2021-11-09 Elorac, Inc. Method for alleviating keratoconjunctivitis sicca
CN112384208A (zh) * 2018-08-23 2021-02-19 埃洛拉克有限公司 用于缓解干燥性角膜结膜炎的方法和组合物
CA3175700A1 (en) * 2021-06-11 2022-12-11 Ankh Life Sciences Limited Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297511A (pt) * 1956-12-20
DK116528A (pt) * 1966-09-30
JPS58500285A (ja) * 1981-03-17 1983-02-24 ビオグラム・アクチエボラーグ 殺菌性組成物
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
AU685262B2 (en) * 1994-03-30 1998-01-15 Gs Development Ab Use of fatty acid esters as bioadhesive substances
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof

Also Published As

Publication number Publication date
ES2860578T3 (es) 2021-10-05
CN105338963A (zh) 2016-02-17
EP2988731A4 (en) 2016-05-18
CA2910114A1 (en) 2014-10-30
AU2014257984B2 (en) 2019-07-11
BR112015027026A8 (pt) 2018-01-30
EP2988731B1 (en) 2021-02-17
PL2988731T3 (pl) 2021-08-02
EP2988731A1 (en) 2016-03-02
HK1224175A1 (zh) 2017-08-18
US20160081968A1 (en) 2016-03-24
WO2014175814A1 (en) 2014-10-30
AU2014257984A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
HK1223975A1 (zh) 含納米氣泡的組合物及其用途
CL2015000128A1 (es) Composición para controlar enfermedades en plantas y el uso de la misma
HK1216004A1 (zh) 固溶體組合物及其在慢性炎症中的用途
CO6831975A2 (es) Inmunoconjugados, composiciones para prepararlos, métodos para prepararlos y uso
BR112015027026A2 (pt) composição para uso na redução da formação de crosta e na promoção da cicatrização
GB201317286D0 (en) Composition and Use
EP3328414A4 (en) COMPOSITION FOR USE IN PROMOTING WOUND HEALING
CL2015002146A1 (es) Composiciones y procedimientos para tratar heridas superficiales
EP3075379A4 (en) Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same
FI2956471T3 (fi) Il-1-beetan estäjän koostumus ja sen käyttö
CL2016000998A1 (es) Composición herbaria, procedimiento para su preparación y uso de la misma
BR112015021722A2 (pt) composição para uso no tratamento de síndrome do ovário policístico
SMT201700004B (it) Uso di estratti di salvia haenkei in composizioni per antisenescenza
HK1223906A1 (zh) 用於建築材料的鳥糞石- 及鉀石膏組合物
CL2014000792A1 (es) Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio
IL245015A0 (en) Medicinal composition containing icotinib for topical treatment of the skin and its use
GB201301979D0 (en) New composition and use thereof
BR112015023621A8 (pt) derivados de meropenem e suas utilizações
BR112015006960A2 (pt) uso de uma combinação, composição e método para preparar um produto de espuma
FR2994385B1 (fr) Composition cosmetique biphasique conditionnee en flacon-pompe
CL2015003706A1 (es) Composiciones vacunales bivalentes y su uso para la terapia de tumores
FR3007291B1 (fr) Composition cicatrisante et utlisation
GB2516064B (en) Improvements in and relating to radar
CL2015002599A1 (es) Composiciones y métodos para la orientación de n-acetilglucosamina transferasa unida al oxigeno y promover sanamiento de heridas
BR112014032456A2 (pt) métodos in vitro, composição farmacêutica, kit para realização do método e método para melhorar o efeito de tratamento

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2555 DE 24/12/2019 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.6 NA RPI NO 2563 DE 18/02/2020 POR TER SIDO INDEVIDA. EM VIRTUDE DO 1.3.4 QUE ANULOU O 1.3.

B350 Update of information on the portal [chapter 15.35 patent gazette]